Immucell, an animal health focused company in Portland is planning an expansion, Mainebiz reports. The manufacturer of Mast Out, a drug that treats mastitis in cows, will build a new facility on the land behind its current location in Portland. The company is also planning additional FDA approvals to bring the animal treatment to the commercial market. Read full story here
Related Posts
Maine’s life sciences sector growth could outpace other industries
Maine’s $2.3 billion life sciences sector, which employed close to 10,000 people in 2024, will outpace the growth of many other...
IDEXX gets wiggle room to buy back more shares
IDEXX Laboratories Inc. (Nasdaq: IDXX), a Westbrook-based maker of veterinary diagnostics and software, has the green light from its board of...
Maine’s first accredited lab for PFAS testing is expanding to meet demand
NORRIDGEWOCK, Maine — This week, the Biden administration moved to prevent dangerous “forever chemicals” from being released onto the market after a less...